Fundamental dimension Equity attribute | BIOSPeer $10.80▼-0.05% Cap $209.1MP/E 54.0x QuantScore52/100 | BLNGWLeader $0.0009▲+350.00% Cap $0P/E 0.0x QuantScore60/100 | CCAIWPeer $0.00150.00% Cap $49.80MP/E 0.0x QuantScore35/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
69/100 |
50/100 |
16/100 |
Valuation Multiples, PEG & DCF upside | 38/100 | 100/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 54/100 | 50/100 | 25/100 |
Growth Revenue / earnings growth & margins | 50/100 | 39/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 54.0x | 0.0x | 0.0x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 182691.6x | 0.5x | -40.9x |
Price / Sales | — | — | — |
Price / Free Cash Flow | -302.4x | — | -58.0x |
PEG ratio | 0.00 | 0.00 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | — | 2 / 9 |
Altman Z-Score | 7.26 (Safe) | — | -1.38 (Distress) |
Total debt / equity | 0.02 | 0.00 | 0.00 |
Quick ratio | 1.0x | 0.1x | 0.8x |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | +3375823.3% | +36.6% | — |
Gross margin (TTM) | 0.0% | 0.0% | 0.0% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | -0.0% | +200.0% | 0.0% |
3M return | +0.8% | -91.0% | 0.0% |
6M return | +2.9% | -98.9% | 0.0% |
Year to date | +5.1% | -99.4% | 0.0% |
1Y return | +6.6% | -98.2% | 0.0% |
3Y return | +10.2% | -99.8% | -99.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | — — | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |